Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2964-2026

Halyard LAVH PACK Recall

Halyard LAVH PACK, Model/Catalog Number: USAR053-11 containing Clearify Visualization System (5303907).

FDA recall Class II

Ongoing

FDA lists this Class II recall for Halyard LAVH PACK. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2964-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jul 10, 2026
FDA report date
Aug 26, 2026
Quantity in commerce
40 packs
Distribution
See key details
FDA cause
Process control

What is being recalled?

Halyard LAVH PACK, Model/Catalog Number: USAR053-11 containing Clearify Visualization System (5303907).

Affected model & UDI checker

Search the exact identifiers published for Z-2964-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
USAR053-11Halyard LAVH PACKCheck source noticeNot specified
Not specifiedHalyard LAVH PACKCheck source notice10809160372357
FDA code information

UDI/DI: 10809160372357, Lot No.: 1669869, Expiration Date: 4/30/2027

View the original FDA recall notice

Why was this product recalled?

The kit component was subjected to EO sterilization, contrary to the manufacturer recommendation, which may have led to the component leaking in a kit.

What actions did AVID Medical, Inc. take?

Owens & Minor issued an URGENT: MEDICAL DEVICE FIELD CORRECTION notice to its consignees on 7/10/2026 via email. The notice explained the issue, potential risks to health, and requested the following: "ACTIONS TO TAKE: " DO NOT USE AND DISCARD the Clearify Visualization System (Component# 5303907) located in the convenience kit identified in Table 1 above. All other components in the kits may continue to be used. " Add warning labels to affected AVID kits to ensure all users are aware of the actions to take prior to use. A labeling template is enclosed for printing labels which can be affixed on all affected kits and cases in inventory. This label should be applied in a prominently visible location to end-users. The location chosen should not cover any other critical product information found on existing product labeling. Please contact your Sales Representative if pre-printed labels are needed. " Customers (end-users): If you have received product from a distributor, please contact the distributor or your sales representative with any questions you may have. " Distributors: If any of the affected kits identified above were further distributed, please ensure all end-users are appropriately notified and maintain records of effectiveness. " Complete the attached Recall Response Form and return by July 22, 2026."

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology